Puma Biotechnology Inc. (PBYI) Has Plunged To An 8-Month Low
The Committee for Medicinal Products for Human Use of the European Medicines Agency revealed a negative trend vote after their meeting with Puma Biotechnology Inc. (PBYI) regarding its breast cancer treatment neratinib.
Source: RTTNews